losartan has been researched along with mirabegron in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cserni, BG; Cserni, G; Csont, T; Dinh, H; Farkas, K; Földesi, I; Freiwan, M; Horváth, P; Kovács, F; Kovács, MG; Kovács, ZZA; Kővári, B; Kriston, A; Márványkövi, FM; Sárközy, M; Siska, A; Szűcs, G | 1 |
| Cserni, G; Csont, T; Dinh, H; Dux, L; Földesi, I; Freiwan, M; Horváth, P; Kovács, F; Kovács, MG; Kovács, ZZA; Kriston, A; Losonczi, R; Sárközy, M; Siska, A; Szűcs, G | 1 |
2 other study(ies) available for losartan and mirabegron
| Article | Year |
|---|---|
Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Antihypertensive Agents; Cardiomyopathies; Losartan; Male; Nephrectomy; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Thiazoles; Uremia | 2021 |
Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model.
Topics: Acetanilides; Animals; Cardiomyopathies; Cardiotoxicity; Doxorubicin; Losartan; Male; Rats; Rats, Wistar; Thiazoles | 2022 |